In bioactive environments, ACE inhibitors can reduce angiotensin (II) production and hence reduce hypertension; for instance, ACE inhibitors are produced from peptides derived from various legumes in vitro, as shown in Table 2. The gene discussed is ACE; the disease is Hypertension.